Logo

Prostate Cancer

News and reporting on prostate cancer.

Prostatype Genomics, Life Genomics Ink Commercialization Deal for Prostate Cancer Test

Prostatype's test is designed to use gene expression and certain clinical measures to determine a prostate tumor's aggressiveness and guide treatment.

Immunovia, Proteomedix to Collaborate on R&D Efforts

The strategic partnership is intended to increase both companies' research and development productivity and efficiency.

P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing

The companies will use Illumina's TruSight Oncology 500 cancer panel to complement P4's UroSeq NGS-based germline testing.

Lucence, National Cancer Centre Singapore to Study Liquid Biopsy Assay in Prostate Cancer

The collaborators will evaluate the use of Lucence's LiquidHallmark assay to help make treatment decisions in Asian men with prostate cancer.

MDxHealth Plans One-Stop Shop for Prostate Cancer Dx With Acquisition of Oncotype GPS Assay
Premium

The company hopes that it can persuade urology practices to go with its suite of assays by covering a fuller range of treatment decision points.

Aug 2, 2022

MDxHealth Acquires Prostate Cancer Testing Business From Exact Sciences for up to $100M

Jul 20, 2022

Treatment-Resistant Prostate Cancer Clues Drawn From Circulating Tumor DNA Dynamics

Jun 17, 2022

Local Coverage Determinations Roundup: Opko Health, Bio-Techne, LynxDx, MDxHealth

Jun 7, 2022

African American Prostate Cancer Patients Get More VUS, Fewer Actionable Results, Studies Show

Jun 6, 2022

Foundation Medicine, Arvinas Partner to Develop CDx For Prostate Cancer Drug

Jun 2, 2022

Caris, Sorrento, Prostate Cancer Clinical Trial Consortium Ink Clinical Trial Partnership

May 20, 2022

Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests

May 11, 2022

Guidelines Update Supports Use of Genomic Tests in Early Prostate Cancer Management

May 4, 2022

Bio-Techne Fiscal Q3 Revenues Rise 19 Percent

Apr 19, 2022

Single-Cell Proteomic Analysis Points to Role of Rare Cell Populations in Localized Prostate Cancer

Apr 18, 2022

Clinical Polygenic Risk Assay, Reporting Pipeline Shows Promise for Multiple Conditions
Premium

Apr 18, 2022

AmoyDx, AstraZeneca Collaborate to Develop, Commercialize Companion Diagnostic Tests

Apr 13, 2022

Common Disease Polygenic Risk Scores Show Poor Cross-Ancestry Performance

Mar 30, 2022

Prostate Cancer Analysis Explores Age-Related Risk Linked to Polygenic Risk Score

Mar 10, 2022

Novigenix, Philips Ink Technology License Agreement for Prostate Cancer Tests

Feb 25, 2022

Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says
Premium

Feb 22, 2022

Million Veterans Study Yields Prostate Cancer Risk Score With Promise for Improved Screening
Premium

Feb 10, 2022

Genetic Cancer Risk Varies by Ancestry in Qatari Population, New Analysis Finds

Jan 10, 2022

23andMe Gains FDA Clearance for Direct-to-Consumer Prostate Cancer Genetic Risk Test

Dec 9, 2021

Rarecells Raises $13M in Series A Round to Develop Liquid Biopsy Early Cancer Detection Tests

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.